Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
#Collagen Verified#Lonza CHI#CHI receives#NutraStrong Collagen#Verified certification
Life Science News
Latest updates from the biotech and pharma world
Executive changes at Lonza - The Pharma Letter
#Pharma Letter#Letter Executive#Pharma#Lonza#Letter
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review
#Lonza Capsules#Health Ingredients#Collagen Verified#SGS Nutrasource#Nutraceutical Business
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire
#Files Patent#Patent Infringement#Infringement Lawsuit#ToolGen Files#Newswire ToolGen
Future-proofing nutraceuticals: Lonza CHI on bioavailability and sensory appeal - nutritioninsight.com
#Lonza CHI#Future-proofing nutraceuticals#sensory appeal#Lonza#CHI
Solving for solubility: Drug formulation for complex molecules - Nature
#Drug formulation#complex molecules#Nature Solving#molecules Nature#Drug
Lonza to Highlight Preservation and Disinfection Solutions - Nonwovens Industry -
#Nonwovens Industry#Highlight Preservation#Disinfection Solutions#Solutions Nonwovens#Industry
Lonza Stover Obituary (2025) - St. Petersburg, Florida - Tampa Bay Times - Legacy | Obituary
#Tampa Bay#Bay Times#Stover Obituary#Lonza Stover#Times Legacy
Excellos, Lonza, and Akadeum Life Sciences Unite to Advance Cell Therapy Manufacturing Through Enhanced Starting Material Quality - PR Newswire
#Akadeum Life#Life Sciences#Sciences Unite#Advance Cell#Cell Therapy
Three amigos: Lonza, Excellos, and Akadeum team to improve CGT landscape - BioProcess International
#Akadeum team#improve CGT#CGT landscape#BioProcess International#Lonza
Preclinical pitfalls: How to avoid costly formulation failures - Nature
#Preclinical pitfalls#avoid costly#costly formulation#formulation failures#Nature Preclinical
Lonza Group First Half 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
#Revenues Beat#Beat Expectations#Yahoo Finance#Lonza Group#Line Yahoo
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
#Vacaville Reporter#Lonza earnings#Vacaville facility#Reporter Vacaville#earnings report
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
#Pharma Letter#Lonza lifts#lifts forecast#performance rebounds#Letter Lonza
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals
#San Francisco#Genentech Vacaville#Francisco Business#Business Times#Business Journals
Lonza tops core profit forecast driven by main drug manufacturing business - Reuters
#Lonza tops#tops core#core profit#profit forecast#forecast driven
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
#Samsung Bio#Lonza posts#Fierce Pharma#pulse check#CDMO pulse
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
#Lonza invest#Pharmaceutical Technology#FDA filing#BioNTech adds#adds CMOs
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
#manufacturing readiness#Lonza leaders#BioSpectrum Asia#gene therapy#Asia Lonza
Strategic planning in ADC development: insights from Lonza - Drug Target Review
#ADC development#Drug Target#Target Review#Lonza Drug#Strategic planning